LSBWF LakeShore Biopharma Co., Ltd.
Price Chart
Executive Summary
LakeShore Biopharma has called an Extraordinary General Meeting (EGM) for June 19, 2026, to vote on a previously announced merger agreement dated November 4, 2025 (as amended April 29, 2026) with Oceanpine Skyline Inc. and its merger sub, which would take the company private and delist its shares and warrants from OTC Markets. The board, on unanimous recommendation of a special committee of independent directors, recommends shareholders vote FOR the proposal.
Actionable Insight
Monitor for the EGM vote outcome on June 19 and any Schedule 13E-3 filings for merger consideration details. If the merger passes, the stock will likely trade near the buyout price until close; if blocked, it could collapse back to pre-deal levels. The 6-K amplifies activist/offering context per cross-filing analysis, suggesting the deal is pivotal for the company's future.
Key Facts
- EGM to vote on going-private merger with Oceanpine Skyline Inc. is scheduled for June 19, 2026.
- Merger Agreement signed November 4, 2025, with Amendment No. 1 dated April 29, 2026.
- If approved, the company will become privately held; shares and warrants delisted from OTC Pink and deregistered under Section 12 of the Exchange Act.
- Board unanimously recommends voting FOR the merger after a special committee of independent directors approved it.
- Shareholders of record as of May 27, 2026 are entitled to vote.
Financial Impact
Merger price per share not disclosed in this filing; delisting implies a fixed premium to OTC-traded price for current shareholders.
Risk Factors
- Shareholder vote could fail — risk of deal termination and stock price decline.
- No merger price disclosed in this filing — terms remain unknown, creating uncertainty on value.
- Financing for the merger may not be available — risk of close failure.
- Post-merger, shares will be illiquid with no public market.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-061817 |
| Document: ea0292493-6k_lakeshore.htm | 0001213900-26-061817 |
| Document: 0001213900-26-061817-index-headers.html | 0001213900-26-061817 |
| Document: 0001213900-26-061817-index.html | 0001213900-26-061817 |
| Document: 0001213900-26-061817.txt | 0001213900-26-061817 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
17d ago
|
6-K
| — | awaiting T+20 | — | — |
|
Apr 29, 2026
6w ago
|
6-K
| — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access